Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Indevus Pharmaceuticals is a biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men’s health conditions. The Company currently co-promotes SANCTURA(R) for overactive bladder and markets DELATESTRYL(R) to treat male hypogonadism and currently has six compounds in clinical development. The compounds in development include SANCTURA XR(TM), the once- daily formulation of SANCTURA, NEBIDO(R) for the treatment of male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually transmitted pathogens, IP 751 for interstitial cystitis, pagoclone for stuttering, and aminocandin for systemic fungal infections. ( www.indevus.com )
Indevus Pharmaceuticals , Inc.
33 Hayden Avenue
Lexington, Massachusetts 02421
USA
Tel: (781) 861-8444
Fax: (781) 861-3830